Kiser Eye Care - Medicare Optometrist in Hickory, NC

Kiser Eye Care is a medicare enrolled "Optometrist" provider in Hickory, North Carolina. Their current practice location is 1960 Us Highway 70 Se, Hickory, North Carolina. You can reach out to their office (for appointments etc.) via phone at (828) 323-8833.

Kiser Eye Care is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Kiser Eye Care is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1417397027.

Contact Information

Kiser Eye Care
1960 Us Highway 70 Se,
Hickory, NC 28602-5106
(828) 323-8833
(828) 322-8687



Healthcare Provider's Profile

Full NameKiser Eye Care
TypeFacility
SpecialityOptometrist
Location1960 Us Highway 70 Se, Hickory, North Carolina
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1417397027
  • Provider Enumeration Date: 06/27/2013
  • Last Update Date: 05/23/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3375784564
  • Enrollment ID: O20130731000339

Medical Identifiers

Medical identifiers for Kiser Eye Care such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1417397027NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Kiser Eye Care acts as a billing entity for following providers:
Provider NameJody D Papazekos
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1730286980
PECOS PAC ID: 3577544766
Enrollment ID: I20040525000710

News Archive

Measure to protect older insured could impact the young

In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

Two new epigenetic regulators maintain self-renewal of embryonic stem cells

Embryonic stem cells have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body.

New partnership provides access to pioneering fluorescent probe technology to understand disease progression

Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.

Read more Medical News

› Verified 8 days ago

Provider NameWilliam C Spangler
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1205992070
PECOS PAC ID: 1052384237
Enrollment ID: I20040816001284

News Archive

Measure to protect older insured could impact the young

In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

Two new epigenetic regulators maintain self-renewal of embryonic stem cells

Embryonic stem cells have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body.

New partnership provides access to pioneering fluorescent probe technology to understand disease progression

Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.

Read more Medical News

› Verified 8 days ago

Provider NameLisa E Graybeal Ziebell
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1750325478
PECOS PAC ID: 7012008444
Enrollment ID: I20070814000321

News Archive

Measure to protect older insured could impact the young

In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

Two new epigenetic regulators maintain self-renewal of embryonic stem cells

Embryonic stem cells have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body.

New partnership provides access to pioneering fluorescent probe technology to understand disease progression

Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.

Read more Medical News

› Verified 8 days ago

Provider NameMelanie S Kiser
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1477696656
PECOS PAC ID: 0042388282
Enrollment ID: I20081001000517

News Archive

Measure to protect older insured could impact the young

In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

Two new epigenetic regulators maintain self-renewal of embryonic stem cells

Embryonic stem cells have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body.

New partnership provides access to pioneering fluorescent probe technology to understand disease progression

Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.

Read more Medical News

› Verified 8 days ago

Provider NameRachael A Wruble
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1588899306
PECOS PAC ID: 6103014758
Enrollment ID: I20101223000033

News Archive

Measure to protect older insured could impact the young

In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

Two new epigenetic regulators maintain self-renewal of embryonic stem cells

Embryonic stem cells have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body.

New partnership provides access to pioneering fluorescent probe technology to understand disease progression

Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.

Read more Medical News

› Verified 8 days ago

Provider NameNilpa Patel
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1104955335
PECOS PAC ID: 8527227727
Enrollment ID: I20120307000647

News Archive

Measure to protect older insured could impact the young

In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

Two new epigenetic regulators maintain self-renewal of embryonic stem cells

Embryonic stem cells have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body.

New partnership provides access to pioneering fluorescent probe technology to understand disease progression

Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.

Read more Medical News

› Verified 8 days ago

Provider NameGlenn C Brewer
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1487935151
PECOS PAC ID: 9133393234
Enrollment ID: I20150330000926

News Archive

Measure to protect older insured could impact the young

In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

Two new epigenetic regulators maintain self-renewal of embryonic stem cells

Embryonic stem cells have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body.

New partnership provides access to pioneering fluorescent probe technology to understand disease progression

Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.

Read more Medical News

› Verified 8 days ago

Provider NameJoseph Faulk
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1235567256
PECOS PAC ID: 5890013882
Enrollment ID: I20150423002213

News Archive

Measure to protect older insured could impact the young

In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

Two new epigenetic regulators maintain self-renewal of embryonic stem cells

Embryonic stem cells have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body.

New partnership provides access to pioneering fluorescent probe technology to understand disease progression

Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.

Read more Medical News

› Verified 8 days ago

Provider NameMichelle M Woo
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1295264380
PECOS PAC ID: 9032542139
Enrollment ID: I20191203003164

News Archive

Measure to protect older insured could impact the young

In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

Two new epigenetic regulators maintain self-renewal of embryonic stem cells

Embryonic stem cells have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body.

New partnership provides access to pioneering fluorescent probe technology to understand disease progression

Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.

Read more Medical News

› Verified 8 days ago

Provider NameAdam Greene
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1598465262
PECOS PAC ID: 1052777497
Enrollment ID: I20230510000881

News Archive

Measure to protect older insured could impact the young

In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

Two new epigenetic regulators maintain self-renewal of embryonic stem cells

Embryonic stem cells have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body.

New partnership provides access to pioneering fluorescent probe technology to understand disease progression

Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kiser Eye Care is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Kiser Eye Care
1960 Us Highway 70 Se,
Hickory, NC 28602-5106

Ph: (828) 323-8833
Kiser Eye Care
1960 Us Highway 70 Se,
Hickory, NC 28602-5106

Ph: (828) 323-8833

News Archive

Measure to protect older insured could impact the young

In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

Two new epigenetic regulators maintain self-renewal of embryonic stem cells

Embryonic stem cells have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body.

New partnership provides access to pioneering fluorescent probe technology to understand disease progression

Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the life science business of Merck, a leading science and technology company in healthcare, life science and performance materials.

Read more News

› Verified 8 days ago


Optometrist in Hickory, NC

Elite Family Eye Care
Optometrist
Medicare: Medicare Enrolled
Practice Location: 2339 Us Highway 70 Se, Hickory, NC 28602
Phone: 919-608-2579    
Heather Hill Day, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 2424 Century Pl Se, Hickory, NC 28602
Phone: 828-332-2205    Fax: 828-345-0522
Jody Dale Papazekos Od
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 27 13th Ave Ne, Hickory, NC 28601
Phone: 828-322-3154    Fax: 828-322-3154
Dr. Robert A Bisanar, O D
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 305 3rd Ave Nw, Hickory, NC 28601
Phone: 828-322-8052    Fax: 828-322-8053
Viewmont Optometry Pllc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 336 10th Avenue Ne, Hickory, NC 28601
Phone: 828-322-4973    Fax: 828-322-1636
Dr. William Mark Sigmon, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1060 Lenoir Rhyne Blvd Se, Hickory, NC 28602
Phone: 828-328-3900    Fax: 828-328-5253
Michelle Woo, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 2266 Us Highway 70 Se, Hickory, NC 28602
Phone: 828-979-3010    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.